patient_pharmacist_image
patient_pharmacist_image

CONTOUR® and HealthTab: Benefits for CONTOUR® users

Blood glucose reporting and lab accurate A1C testing – together in a single diabetes management platform at your local pharmacy.

Yves headshot
Yves headshot

Discover Yves' story

Follow along Yves' journey with Type 2 diabetes and the CONTOUR®NEXT ONE and CONTOUR®DIABETES app System. See how he managed to go insulin free.

REGISTER YOUR METER
REGISTER YOUR METER

Register your CONTOUR® meter

  • Ensure easy warranty replacement process
  • Set access to future information and offers from Ascensia

Contour Next Gen
Contour Next Gen

CONTOUR®NEXT GEN

  • Easy to use
  • High accuracy1
  • smartlight® for easier understanding of blood glucose readings2
  • Can save test strips with Second-Chance Sampling technology3
  • Connect to the free Contour®DIABETES app**
Contour Diabetes App
Contour Diabetes App

CONTOUR®DIABETES app

  • Get results when test reading are critically high or low.
  • Discover insights on your blood glucose pattern
  • Ser reminders for when your next test is due
  • Sharing reading directly with Your Healthcare Professional
Contour Next One
Contour Next One

CONTOUR®NEXT ONE

  • Easy and intuitive to use
  • Highly accurate1 within ± 8,4 % of lab values*
  • Second-Chance® sampling (up to 60 seconds)
  • Works with the free CONTOUR®DIABETES app
ascensia_logo
ascensia_logo

Ascensia Diabetes Care is dedicated to improving the health and lives of people with diabetes

We are home to the world-renowned CONTOUR® portfolio of blood glucose monitoring systems.
1. CONTOUR®NEXT GEN Blood Glucose Monitoring System User Guide, Rev. 09/20.
2. Ascensia Diabetes Care. Data on file. Smartson online survey, Sweden 2017. 352 respondents: People with type 1 and type 2 diabetes, over 18 years old, who tested at least 4-7 times a day. Participants received free meter and tests strips. Survey funded by Ascensia Diabetes Care.
3. Richardson JM et al. Clinical Relevance of Reapplication of Blood Samples During Blood Glucose Testing. Poster presented at the 20th Annual Diabetes Technology Meeting (DTM); November 12-14, 2020.

*In a clinical study, conducted in accordance with the requirements of ISO 15197:2013, the CONTOUR®NEXT ONE not only met and exceeded the minimum require- ments of the standard but an ad hoc analysis determined where 95% of results fell during the study, which was within ±0.47 mmol/L or ±8.4% of the laboratory reference value for glucose concentrations <5.55 mmol/L or ≥5.55 mmol/L, respectively, when tested via subject obtained capillary fingertip results (patients with diabetes)

**On a compatible Android and iOS device. For a list of compatible operating systems, please visit http://compatibility.contourone.com/.